What are the recent financial highlights of WANBURY LIMITED?

WANBURY LIMITED recently reported a total revenue of ₹566.92 Cr and a net profit margin of 7.75%. These metrics reflect the company’s consistent financial performance.

What are the key financial metrics of WANBURY LIMITED?

Key financial metrics include a trailing P/E ratio of 17.809013, forward P/E of , book value of ₹11.79, price-to-book ratio of 19.772688, and a market capitalization of ₹7.65 billion.

What does WANBURY LIMITED do?

Wanbury Limited manufactures and sells formulations and active pharmaceutical ingredients (API) in India and internationally. The company offers formulations for gynecology, orthopedics, hematinic, anti-diabetic, nutraceuticals, gastro intestinal, stroke surgery, antibiotics, cough and cold solutions, anti-inflammatory, analgesics, and general practitioner. It also provides API products for anti-diabetic, anti-analgesic, anti-depressant, anti-histaminic, anti-inflammatory, anti-arthritis, anti-thrombotic, anti-epileptic, and anti-hypertensive therapeutic areas. The company was formerly known as Pearl Organics Limited and changed its name to Wanbury Limited in 2004. Wanbury Limited was incorporated in 1988 and is headquartered in Navi Mumbai, India.

Loading...

₹ 0 0.00%

Loading... BSE: Loding... NSE: Wanbury

About

Loading... ^[1]

Website BSE NSE

Market Cap ₹ 0 Cr.
Current Price ₹ 0
High / Low ₹ 0 / 0
Stock P/E
Dividend Yield 0 %
ROE 0 %
EPS 0
P/B Ratio 0
Net Profit Margin 0 %
Debt to Equity 0
ROCE 0 %
Interest Coverage 0 %

Stock News - Wanbury

Latest updates related to Wanbury

Sr No.	Title	Sentiment
1	Wanbury refinances $150 cr debt, cuts interest costs significantly BusinessLine	🔄
2	Wanbury edges higher post conclusion of NCD refinancing at lower rates Business Standard	🔄
3	Wanbury Consolidated December 2024 Net Sales at Rs 133.45 crore, down 8.28% Y-o-Y Moneycontrol	🔄
4	WANBURY Share Price Today Up 12% Equitymaster	🔄
5	Wanbury reports 88% drop in Q3 FY25 PAT Indian Pharma Post	🔄
6	Wanbury Experiences Revision in Its Stock Evaluation Amidst Strong Market Performance MarketsMojo	🔄
7	Wanbury appoints Prakash Venkatraman as President of API business Express Pharma	🔄
8	Wanbury appoints Prakash Venkatraman as President of API business BSI bureau	🔄
9	Wanbury Shares Hit 5% Upper Circuit on API Pipeline and Launches EquityPandit	🔄
10	Benign Growth For Wanbury Limited (NSE:WANBURY) Underpins Stock's 28% Plummet Simply Wall St	🔄

Peer Comparison

Macro Industry: Loading.. | Sector: Loading.. | Industry: Loading.. | Basic Industry: Loading..

Loading peers table...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Loading data...

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Loading Profit & Loss data...

Compounded Sales Growth
10 Years:
5 Years:
3 Years:
TTM:

Compounded Profit Growth
10 Years:
5 Years:
3 Years:
TTM:

Stock Price CAGR
10 Years:
5 Years:
3 Years:
1 Year:

Return on Equity
10 Years:
5 Years:
3 Years:
Last Year:

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Shareholding Pattern

Numbers in percentages

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Delivery Data

Insider Data

Technical Data

Static Application Security Testing

Documents

Announcements

Annual reports

Right Issue

Credit ratings

Concalls

Explore More Stocks

GOPAL ORTINGLOBE EXCELINDUS ACLGATI TRIDENT UJJIVANSFB NITIRAJ GOCOLORS ONDOOR STAR